Comedy from the competition: A new twist in the Ivermectin debate

Comedy from the competition: A new twist in the Ivermectin debate

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

[Corrected from the version of 8/23/2021: the first article cited below1 shows a photo of ivermectin from Cali, Colombia, but the Eduardo Medina who wrote it is not the researcher of that name from that city.]

Many news articles published on August 21, 2021, including these four,1-4 furnished alarming reports about calls to a poison control center in Mississippi from people who took ivermectin in unspecified animal formulations. But no hospitalizations actually resulted.5 One of these articles listed several serious side effects associated with ivermectin use, but muddied the distinction between this drug in human or veterinary formulations,1 some of the latter of which are not for internal use. 

In fact, Ivermectin, a drug of Nobel prize-honored distinction, is one of the safest drugs in modern medicine, well tolerated even at ten times the standard dose of 200 µg/kg,6,7 including for COVID-19 treatment.8,9 Ivermectin has been used safely in 3.7 billion doses worldwide since 1987 to treat a variety of human diseases.10-12 Cancer patients who were...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee